Nova Pharma Solutions Bhd (XKLS:03006) Cash-to-Debt : 136.58 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nova Pharma Solutions Bhd's cash to debt ratio for the quarter that ended in Dec. 2023 was 136.58.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nova Pharma Solutions Bhd could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Nova Pharma Solutions Bhd's Cash-to-Debt or its related term are showing as below:

XKLS:03006' s Cash-to-Debt Range Over the Past 10 Years
Min: 42.49 Med: 159.18 Max: No Debt
Current: 136.58

During the past 9 years, Nova Pharma Solutions Bhd's highest Cash to Debt Ratio was No Debt. The lowest was 42.49. And the median was 159.18.

XKLS:03006's Cash-to-Debt is not ranked
in the Construction industry.
Industry Median: 0.62 vs XKLS:03006: 136.58

Nova Pharma Solutions Bhd Cash-to-Debt Historical Data

The historical data trend for Nova Pharma Solutions Bhd's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Nova Pharma Solutions Bhd Cash-to-Debt Chart

Nova Pharma Solutions Bhd Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

42.49

55.51

159.18

47.79

136.58

Nova Pharma Solutions Bhd Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial											159.18	208.68	47.79	91.26	136.58

Competitive Comparison of Nova Pharma Solutions Bhd's Cash-to-Debt

For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Pharma Solutions Bhd's Cash-to-Debt Distribution in the Construction Industry

For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Nova Pharma Solutions Bhd's Cash-to-Debt falls into.

Nova Pharma Solutions Bhd Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nova Pharma Solutions Bhd's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	13.521	/	(0.058	+	0.041)
	=	136.58

Nova Pharma Solutions Bhd's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	13.521	/	(0.058	+	0.041)
	=	136.58

Nova Pharma Solutions Bhd (XKLS:03006) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Nova Pharma Solutions Bhd Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650

Website

http://www.novapharmasolutions.com

Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines